Efficacy and safety of camostat mesylate in early COVID-19 disease in an ambulatory setting: a randomized placebo-controlled phase II trial., Tobback, Els, Degroote Sophie, Buysse Sabine, Delesie Liesbeth, Van Dooren Lucas, Vanherrewege Sophie, Barbezange Cyril, Hutse Veronik, Romano Marta, Thomas Isabelle, et al. , Int J Infect Dis, 2022 Sep, Volume 122, (2022)